NON-INFERIORITY DESIGNS OVER THE LAST DECADE OF CONTEMPORARY CARDIOVASCULAR CLINICAL TRIALS

被引：0
|
作者：
Vaduganathan, Muthiah
Patel, Ravi
Tahhan, Ayman Samman
Kalogeropoulos, Andreas
Georgiopoulou, Vasiliki
Fonarow, Gregg
Gheorghiade, Mihai
Butler, Javed
机构：
[1] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] SUNY Stony Brook, Div Cardiol, Stony Brook, NY 11794 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(16)31928-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1156-387
引用
收藏
页码：1927 / 1927
页数：1
相关论文
共 50 条
  • [41] Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials
    Lai, TL
    Shih, MC
    Zhu, GR
    STATISTICS IN MEDICINE, 2006, 25 (07) : 1149 - 1167
  • [42] Non-inferiority clinical trials: Practical issues and current regulatory perspective
    Gupta, Sandeep K.
    INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (04) : 371 - 374
  • [43] Bayesian Design of Non-inferiority Clinical Trials Via the Bayes Factor
    Li W.
    Chen M.-H.
    Wang X.
    Dey D.K.
    Statistics in Biosciences, 2018, 10 (2) : 439 - 459
  • [44] Editorial on hypothesis and objectives in clinical trials: superiority, equivalence and non-inferiority
    Gonzalez, Claudio D.
    Bolanos, Ricardo
    de Sereday, Martha
    THROMBOSIS JOURNAL, 2009, 7
  • [45] Editorial on hypothesis and objectives in clinical trials: superiority, equivalence and non-inferiority
    Claudio D Gonzalez
    Ricardo Bolaños
    Martha de Sereday
    Thrombosis Journal, 7 (1)
  • [46] Non-inferiority versus equivalence clinical trials in assessing biological products
    Pinto, Valdair Ferreira
    SAO PAULO MEDICAL JOURNAL, 2011, 129 (03): : 183 - 184
  • [47] Improving the reporting of non-inferiority trials by incorporating non-efficacy benefits: not all non-inferiority trials are created equal
    Sergio A. Acuna
    Fahima Dossa
    Tyler R. Chesney
    European Journal of Epidemiology, 2021, 36 : 1097 - 1101
  • [48] Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trials
    Bikdeli, Behnood
    Caraballo, Cesar
    Welsh, John
    Ross, Joseph S.
    Kaul, Sanjay
    Stone, Gregg W.
    Krumholz, Harlan M.
    CLINICAL TRIALS, 2020, 17 (06) : 723 - 728
  • [49] A mixed approach for proving non-inferiority in clinical trials with binary endpoints
    Rousson, Valentin
    Seifert, Burkhardt
    BIOMETRICAL JOURNAL, 2008, 50 (02) : 190 - 204
  • [50] A note on the determination of non-inferiority margins with application in oncology clinical trials
    Yu, Binbing
    Yang, Harry
    Sabin, Antony
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2019, 16
12345